Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.72 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.67 |
| ▸ | SELP | P16109 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | PRKCA | P17252 | 2/20 | 0.60 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.60 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.60 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.60 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.59 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.59 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.57 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.57 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.55 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28505996 | 0.94 | FABP3 (0.81) | FABP3S1PR1SELPALDH1A1PRKCA | |
| SCHEMBL31106468 | 0.94 | FABP3 (0.81) | FABP3S1PR1SELPALDH1A1PRKCA | |
| SCHEMBL30842177 | 0.94 | FABP3 (0.81) | FABP3S1PR1SELPALDH1A1PRKCA | |
| SCHEMBL31362195 | 0.94 | FABP3 (0.81) | FABP3S1PR1SELPALDH1A1PRKCA | |
| SCHEMBL31425003 | 0.94 | FABP3 (0.81) | FABP3S1PR1SELPALDH1A1PRKCA | |
| SCHEMBL21680883 | 0.94 | FABP3 (0.81) | FABP3S1PR1SELPALDH1A1PRKCA | |
| SCHEMBL28505997 | 0.94 | FABP3 (0.81) | FABP3S1PR1SELPALDH1A1PRKCA | |
| SCHEMBL30605184 | 0.94 | FABP3 (0.81) | FABP3S1PR1SELPALDH1A1PRKCA | |
| SCHEMBL31400386 | 0.94 | FABP3 (0.81) | FABP3S1PR1SELPALDH1A1PRKCA | |
| SCHEMBL9611246 | 0.94 | FABP3 (0.81) | FABP3S1PR1SELPALDH1A1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | KISBEE THERAPEUTICS INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-20230136465-A1 | PLANT-BASED CHICKEN FLAVORING AGENT COMPOSITION | NotCo Delaware AI, LLC | 2023-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | APOB, APOL1, LDLR | FABP3 20/4885S1PR1 685/4885SELP 158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.